Publication | Closed Access

Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial

UrologyCancer DetectionCancer ScreeningMedicineProstate BiopsiesNon-inferiority TrialProstatic DiseaseMri-guided Radiation TherapyOncologyRadiology